Benefits and Harms of Dementia Screening for Family Members of Older Adults: A Randomized Clinical Trial
Listen to this summary
This randomized clinical trial aimed to evaluate the benefits and risks of dementia screening for family members of older adults in primary care settings. The study found that screening did not lead to significant improvements in family members' health-related quality of life, caregiver preparedness, or caregiving self-efficacy, nor did it increase levels of depression or anxiety among family members. The low rates of positive screenings and high refusal rates for follow-up assessments may explain these findings.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from JAMA internal medicine
View all →May 4, 2026 · JAMA internal medicine
Federal Enforcement Actions Against Medicare Advantage Plans
May 4, 2026 · JAMA internal medicine
Treatment of Anxiety for Adults in Primary Care Settings: A Review
Apr 27, 2026 · JAMA internal medicine
Mailed Outreach for Colorectal Cancer Screening in Community Health Centers: The CARES Pragmatic Cluster Randomized Clinical Trial
Apr 27, 2026 · JAMA internal medicine
The Oncology Care Model and Initiation of Systemic Therapy for Cancer
Apr 20, 2026 · JAMA internal medicine
Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease: A Randomized Clinical Trial
Apr 13, 2026 · JAMA internal medicine
Deprescribing Intervention and Reduction of Proton Pump Inhibitor Use in Primary Care: A Cluster Randomized Clinical Trial
More in Internal Medicine
View all →May 10, 2026 · JAMA
Digoxin in Patients With Symptomatic Rheumatic Heart Disease: A Randomized Clinical Trial
May 10, 2026 · European heart journal
Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial
May 10, 2026 · Lancet (London, England)
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication
May 10, 2026 · European heart journal
Renin-angiotensin-aldosterone system inhibition and haemocompatibility-related adverse events in patients with durable left ventricular assist device: the MOMENTUM-3 trial
May 10, 2026 · JAMA
Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis
May 10, 2026 · Lancet (London, England)
Impact of introducing RTS,S/AS01<sub>E</sub> malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
